|
|
Vaccine Detail
|
OVA-TEXO |
| Vaccine Information |
- Vaccine Name: OVA-TEXO
- Target Pathogen: Cancer
- Target Disease: Cancer
- Product Name: Xie et al., 2013
- Vaccine Ontology ID: VO_0007648
- Type: T cell-based vaccine
- Status: Research
- Immunization Route: Intramuscular injection (i.m.)
- Description: OVA-TEXO immunization induced an OVA-specific CD8+ T-cell response in vivo that was more efficient than the DCOVA-stimulated CTL response, (Xie et al., 2013)
|
| Host Response |
|
|
| References |
Xie et al., 2013: Xie Y, Wang L, Freywald A, Qureshi M, Chen Y, Xiang J. A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling. Cellular & molecular immunology. 2013; 10(1); 72-77. [PubMed: 23042534].
|
|
